C12N2730/10111 - CPC Classification Index

ClassID:

110223 ⎘

C12N2730/10111 - CPC Classification

Classification description:

Reverse transcribing DNA viruses; Details; Hepadnaviridae Orthohepadnavirus, e.g. hepatitis B virus

Sub-classes:

C12N2730/10121 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 12
C12N2730/10122 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 339
C12N2730/10123 » Virus like particles [VLP] 93
C12N2730/10131 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 2
C12N2730/10132 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 8
C12N2730/10133 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 21
C12N2730/10134 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 443
C12N2730/10141 » Use of virus, viral particle or viral elements as a vector 4
C12N2730/10151 » Methods of production or purification of viral material 26
C12N2730/10161 » Methods of inactivation or attenuation 2
C12N2730/10171 » Demonstrated in vivo effect 51
C12N2730/10188 » For redistribution 0

Recent Application in this class:

20250340868

2025-11-06

POLYNUCLEOTIDES ENCODING LINKED ANTIGENS AND USES THEREOF

20230303663

2023-09-28

Antibodies that potently neutralize hepatitis B virus and uses thereof

20230012022

2023-01-12

CANCER VACCINES AND METHODS OF TREATMENT USING THE SAME

20220112515

2022-04-14

Method for Producing Virus-Infected Cell Line and Animal Model

20210040183

2021-02-11

Antibodies that potently neutralize hepatitis B virus and uses thereof

20200181142

2020-06-11

Derivatives And Methods Of Treating Hepatitis B Infections

20190194191

2019-06-27

Derivatives and methods of treating hepatitis B infections

20190184010

2019-06-20

Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines

20190077800

2019-03-14

Derivatives and methods of treating hepatitis B infections

#10

20190031653

2019-01-31

Derivatives and methods of treating hepatitis B infections

#11

20190016785

2019-01-17

Antibodies that potently neutralize hepatitis B virus and uses thereof

#12

20180127415

2018-05-10

Derivatives and methods of treating hepatitis B infections

#13

20170158691

2017-06-08

Derivatives and methods of treating hepatitis B infections

#14

20170121329

2017-05-04

Derivatives and methods of treating hepatitis B infections

#15

20170121328

2017-05-04

Derivatives and methods of treating hepatitis B infections

#16

20160251661

2016-09-01

Treating hepatitis virus infection by modulating microRNAs miR-130a, miR-130b, miR-204, or miR-1236

#17

20160030536

2016-02-04

Cancer vaccines and methods of treatment using the same

#18

20150010590

2015-01-08

Immunogenic POTE peptides and methods of use

#19

20130039936

2013-02-14

Immunogenic POTE peptides and methods of use

#20

20110195407

2011-08-11

NUCLEIC ACID OCCURRING IN BLOOD FROM HEPATITIS PATIENT, POLYPEPTIDE ENCODED BY THE NUCLEIC ACID, AND USES OF THE SAME

#21

20110123624

2011-05-26

Formulations comprising aminosterols

#22

20100297023

2010-11-25

Lipid

#23

20100272745

2010-10-28

VACCINES FOR MALARIA

#24

20100136520

2010-06-03

DETECTING HEPATITIS B VIRUS

#25

20100034840

2010-02-11

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE TO ESCAPE MUTANTS OF TARGETED THERAPIES

#26

20090221497

2009-09-03

Immunodynamic complexes and methods for using and preparing such complexes

#27

20070105094

2007-05-10

WATER-SOLUBLE CATIONIC MAGNETIC FINE PARTICLES AND METHOD FOR SEPARATING OR DETECTING LIPID VESICLE USING THE SAME

#28

20070059311

2007-03-15

Regulation of the hedgehog signaling pathway and uses thereof

#29

20060292170

2006-12-28

Vaccine Composition Against Malaria

#30

20050266422

2005-12-01

Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides

#31

20050265963

2005-12-01

Immunodynamic complexes and methods for using and preparing such complexes

#32

20050249699

2005-11-10

Immunodynamic complexes and methods for using and preparing such complexes

#33

20050220883

2005-10-06

Microparticles with adsorbed polypeptide-containing molecules